A proposal submitted by former CIPHR faculty member Christine Lary, who left MHIR for a position at the Roux Institute in October, was funded by NIH at the end of September. Molecular and cellular mechanisms of prevention of bone loss by beta blockers was funded under PAR-21-055, Mechanistic Ancillary Studies to Ongoing Clinical Projects, as an ancillary study to a project led by researchers at the Mayo Clinic and MHIR’s Cliff Rosen. While Dr. Lary is now at the Roux, the grant was awarded to MaineHealth and the two institutions will work together to transfer the award to Northeastern (Roux). Katie Motyl is named as key personnel in the NOA and she and Aaron Brown will be collaborators of Dr. Lary. Once the transfer from MH to Northeastern is complete, NU will issue a subaward back to MH to support Drs. Motyl and Brown. Congratulations to all three investigators!